OncoMatch/Clinical Trials/NCT07779135
Effect of Aromatherapy on the Management of Chemotherapy-Induced Neuropathy (CIN)
Is NCT07779135 recruiting? Yes, currently enrolling (Sep 2026).
The main objective of this study is to describe the effect of an essential oil-based blend applied topically in the management of painful symptoms, sensory disturbances, or functional impairment caused by Chemotherapy-Induced Neuropathy (CIN) in breast cancer patients who have undergone paclitaxel treatment.
Check if I qualifyExtracted eligibility criteria
Cancer type
Breast Carcinoma
Demographics
Prior therapy
Must have received: taxane (paclitaxel)
occurring in the context of paclitaxel treatment (during or after treatment)
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07779135 currently recruiting?
Yes, this trial is currently recruiting patients.
Is prior treatment required for enrollment?
Yes. Patients must have previously received taxane.
Is this trial open to male patients?
No. This trial enrolls female patients only.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages